Hartmut Döhner
Impact in
- Hematology top 0.01%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Genetics top 0.01%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 356
- Acute Myeloid Leukemia Research 291
- Chronic Myeloid Leukemia Treatments 115
- Genetics 294
- Chronic Lymphocytic Leukemia Research 218
- Myeloproliferative Neoplasms: Diagnosis and Treatment 74
- Co-authors
- Stephan Stilgenbauer (204 shared papers)Konstanze Döhner (200 shared papers)Peter Lichter (86 shared papers)Lars Bullinger (118 shared papers)Clara D. Bloomfield (11 shared papers)Richard F. Schlenk (132 shared papers)Axel Benner (49 shared papers)Daniel J. Weisdorf (1 shared paper)
- Journals
- Blood (287 papers)Journal of Clinical Oncology (51 papers)Leukemia (39 papers)Haematologica (19 papers)British Journal of Haematology (18 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Hartmut Döhner
647 papers receiving 46.0k citations
Hartmut Döhner's Hit Papers
Peers
Comparison fields: 5 of 174
- Hematology 20.9k
- Genetics 18.4k
- Pathology and Forensic Medicine 10.8k
- Immunology 8.4k
- Cancer Research 4.7k
Countries citing papers authored by Hartmut Döhner
This map shows the geographic impact of Hartmut Döhner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hartmut Döhner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hartmut Döhner more than expected).
Fields of papers citing papers by Hartmut Döhner
This network shows the impact of papers produced by Hartmut Döhner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hartmut Döhner. The network helps show where Hartmut Döhner may publish in the future.
Co-authors
The 25 scholars most cited alongside Hartmut Döhner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 669 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet Hit paper breakdown → | 2009 | 2443 |
| 2 | Acute Myeloid Leukemia Hit paper breakdown → | 2015 | 2379 |
| 3 | Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia Hit paper breakdown → | 2000 | 2379 |
| 4 | Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines Hit paper breakdown → | 2008 | 2271 |
| 5 | Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia Hit paper breakdown → | 2008 | 1168 |
| 6 | Acute myeloid leukaemia Hit paper breakdown → | 2006 | 1018 |
| 7 | iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL Hit paper breakdown → | 2018 | 1013 |
| 8 | Use of Gene-Expression Profiling to Identify Prognostic Subclasses in Adult Acute Myeloid Leukemia Hit paper breakdown → | 2004 | 746 |
| 9 | Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalances Hit paper breakdown → | 1997 | 738 |
| 10 | Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm Hit paper breakdown → | 2002 | 688 |
| 11 | Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet Hit paper breakdown → | 2008 | 656 |
| 12 | Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations Hit paper breakdown → | 2005 | 644 |
| 13 | Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission Hit paper breakdown → | 2009 | 644 |
| 14 | V H mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia Hit paper breakdown → | 2002 | 627 |
| 15 | High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia Hit paper breakdown → | 2009 | 615 |
| 16 | IDH1andIDH2Mutations Are Frequent Genetic Alterations in Acute Myeloid Leukemia and Confer Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia WithNPM1Mutation WithoutFLT3Internal Tandem Duplication Hit paper breakdown → | 2010 | 602 |
| 17 | 1993 | 475 | |
| 18 | 2010 | 433 | |
| 19 | 2011 | 427 | |
| 20 | 2005 | 416 |
About Hartmut Döhner
Hartmut Döhner is a scholar working on Hematology, Genetics, Molecular Biology, Immunology and Pathology and Forensic Medicine, having authored 669 papers that have together received 47.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (291 papers), Chronic Lymphocytic Leukemia Research (218 papers), Lymphoma Diagnosis and Treatment (119 papers), Chronic Myeloid Leukemia Treatments (115 papers), Immunodeficiency and Autoimmune Disorders (76 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (74 papers), Acute Lymphoblastic Leukemia research (62 papers) and Protein Degradation and Inhibitors (57 papers). The work is most often cited by research in Hematology (20.9k citations), Genetics (18.4k citations), Pathology and Forensic Medicine (10.8k citations), Immunology (8.4k citations) and Cancer Research (4.7k citations). Hartmut Döhner has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Stephan Stilgenbauer, Konstanze Döhner, Peter Lichter, Lars Bullinger, Clara D. Bloomfield, Richard F. Schlenk, Axel Benner, Daniel J. Weisdorf, Elihu H. Estey and Stefan Fröhling. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia, Haematologica and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.